Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients.

MLA

Liem, Kin Seng, et al. “Maintained Virological Suppression and Renal Function with Reduced Dose Tenofovir Disoproxil Fumarate in Renally Impaired Chronic Hepatitis B Patients.” Journal of Viral Hepatitis, vol. 28, no. 1, Jan. 2021, pp. 51–60. EBSCOhost, https://doi.org/10.1111/jvh.13401.

APA

Liem, K. S., Wong, D. K., Fung, S., Zahirieh, A., Yim, C., Zanjir, W. R., Feld, J. J., Hansen, B. E., & Janssen, H. L. A. (2021). Maintained virological suppression and renal function with reduced dose tenofovir disoproxil fumarate in renally impaired chronic hepatitis B patients. Journal of Viral Hepatitis, 28(1), 51–60. https://doi.org/10.1111/jvh.13401

Chicago

Liem, Kin Seng, David K Wong, Scott Fung, Alireza Zahirieh, Colina Yim, Wayel R Zanjir, Jordan J Feld, Bettina E Hansen, and Harry L A Janssen. 2021. “Maintained Virological Suppression and Renal Function with Reduced Dose Tenofovir Disoproxil Fumarate in Renally Impaired Chronic Hepatitis B Patients.” Journal of Viral Hepatitis 28 (1): 51–60. doi:10.1111/jvh.13401.